Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 351 to 360 of 1461

TitleReference numberPublishedLast updated
Zanubrutinib for treating Waldenstrom's macroglobulinaemiaTA833
Fostamatinib for treating refractory chronic immune thrombocytopeniaTA835
Pembrolizumab for adjuvant treatment of renal cell carcinomaTA830
O2matic PRO 100 for optimising oxygen treatment in respiratory conditionsMIB308
Oral azacitidine for maintenance treatment of acute myeloid leukaemia after induction therapyTA827
Ozanimod for treating moderately to severely active ulcerative colitisTA828
Magtrace and Sentimag system for locating sentinel lymph nodes for breast cancerHTG642
Signatera for detecting molecular residual disease from solid tumour cancersMIB307
Upadacitinib for treating active ankylosing spondylitisTA829
Postnatal careQS37

Results per page

  1. 10
  2. 25
  3. 50
  4. All